Investigators aim to assess the feasibility of delivering two augmentation interventions, Meditation and a Health Enhancement Program, for potentially enhancing the quality of life and mental health of Irreversible Age-Related Vision Loss (IARVL) patients and/or their caregivers.
Patients with irreversible age-related vision loss (IARVL) and have ongoing significant disability and/or their caregivers who agree to consent.
IARVL patients between age 60 to 85 years or caregivers between 18 to 85 years.
Deemed competent to provide individual consent to participate.
Speak and understand English without requirement for interpretation or assistance.
Inability to provide informed consent.
Dementia as defined by MoCA < 21.
Have significant suicidal ideation as per self-report (CES-D = 3 on item question 14 and/or 15).
Have severe depression CES-D ≥ 24.